Abstract
Endothelial progenitor cells (EPCs) are undifferentiated cells with the capacity to mature into endothelial cells (ECs). EPCs have garnered considerable attention in the fields of regenerative medicine and cardiovascular therapy, owing to their pivotal role in neovascularization and vascular repair. Nonetheless, numerous challenges and questions persist regarding the translational research and practical application of EPCs. This review aims to examine the varying definitions of EPCs, their classification, extraction methods, and sources. It will also address the optimization of cultivation techniques for EPCs and the reprogramming of EPCs into induced pluripotent stem cells (iPSCs). Furthermore, the review will delve into the role of EPCs in cardiovascular diseases (CVD), septic shock, and rheumatic immune conditions, as well as their implications in connective tissue diseases (CTDs) and skin soft tissue regeneration. Finally, the article will discuss future research prospects for EPCs, aiming to engage and inspire readers.